Q2 EARNINGS: Medtronic shares up on in-line quarter
This article was originally published in Clinica
Executive Summary
Medtronic’s second-quarter sales of $4.37bn and adjusted earnings of $0.96 were in line with analyst expectations, while its $43bn purchase of Covidien is on track to close in early 2015, the company said.